COMP <GO>
EMBC vs TMCI // ALTMAN Z-SCORE & DEBT/EQUITY
Embecta Corp. (NASDAQ) VS. Treace Medical Concepts Inc. (NASDAQ) • 15-METRIC TALLY: EMBC 6
— TMCI 3
■ METRIC PARITY
LAST: $6.56 (+1.55%) • MKT CAP: $371.7M
balance-sheet
—
LAST: $5.06 (+4.76%) • MKT CAP: $329.1M
balance-sheet
0.90
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMBC VS. TMCI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMBC | TMCI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.60% | 79.80% | -17.20 | TMCI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 35.50% | -32.40% | +67.90 | EMBC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.1x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -8.96% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 22.40% | -25.50% | +47.90 | EMBC | /operating-margins <GO> |
| Net Profit Margin | 8.80% | -27.70% | +36.50 | EMBC | /net-margins <GO> |
| Revenue Growth (YoY) | -3.80% | 1.60% | -5.40 | TMCI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 9.42% | 0.00% | +9.42 | EMBC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | 0.90 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 4/9 | +3.00 | EMBC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.3 | 62.7 | -4.40 | TMCI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 3.6x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $371.7M | $329.1M | $42.6M | EMBC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMBC REV | TMCI REV | EMBC GROSS % | TMCI GROSS % | EMBC FCF | TMCI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.08B | $212.7M | 62.6% | 79.8% | $182.4M | -$29.5M |
| FY 2024 | $1.12B | $209.4M | 65.5% | 80.4% | $19.9M | -$48.8M |
| FY 2023 | $1.12B | $187.1M | — | — | $67.7M | -$34.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMBC // BETA —
TMCI // BETA —